KC F1-F2 Referanslar

Print
Print
1- Cline JC. Nutritional aspects of detoxification in clinical practice. Altern Ther Health Med. 2015 May-Jun;21(3):54-62.
2- Veith A, Moorthy B. Role of cytochrome p450s in the generation and metabolism of reactive oxygen species. Current Opinion in Toxicology. 2018;7:44–51.
3- Matias M, et al. Cytochrome P450-mediated toxicity of therapeutic drugs. In: Cytochrome P450 Enzymes: Biochemistry, Pharmacology and Health Implications. Shangai, China: Nova Science; 2014. p. 13–50.
4- Hodges RE, Minich DM. Modulation of metabolic detoxification pathways using foods and food-derived components: A scientific review with Clinical Application. Journal of Nutrition and Metabolism. 2015;2015:1–23.
5-Naik A, et al. Molecular interactions between NAFLD and xenobiotic metabolism. Frontiers in Genetics. 2013;4.
 

KC Norm Referanslar

KC Norm
1- Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian Journal of Endocrinology and Metabolism. 2018;22(3):421.
2- Wang D, He B. Current perspectives on nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022;Volume 15:1281-91.
3- Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology. 2009;51(2):679-89.
4- David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev. 2010;6:73-80.
5- Piantanida E, Ippolito S, Gallo D, Masiello E, Premoli P, Cusini C, et al. The interplay between thyroid and liver: Implications for clinical practice. Journal of Endocrinological Investigation. 2020;43(7):885-99.
6- Cline JC. Nutritional aspects of detoxification in clinical practice. Altern Ther Health Med. 2015 May-Jun;21(3):54-62.
ASRAP